Everest reported third quarter 2026 net income of $233 million, or $6.12 per diluted share, compared with $255 million, or $6.09, a year earlier. The results included $268 million of unfavorable prior-year reserve development and a pre-tax underwriting loss of $223 million for the group, while the company repurchased $474 million of common shares during the quarter.
Net income of $233 million ($6.12 per diluted share) vs. $255 million ($6.09) in Q3 2025
Net operating income of $290 million ($7.62 per diluted share) vs. $316 million ($7.54) in Q3 2025
Group combined ratio affected by $268 million of unfavorable prior-year reserve development; Core businesses combined ratio was 105.8%
Common share repurchases of $474 million in the quarter; book value per share was $381.04 at September 30, 2026
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Everest Group's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$17.50B
+1.2%
$37.80
+18.9%
9.1%
FY2024
$17.28B
+18.5%
$31.78
-47.2%
7.9%
FY2023
$14.59B
+21.0%
$60.19
+296.2%
17.3%
FY2022
$12.06B
+1.6%
$15.19
-56.1%
5.0%
FY2021
$11.87B
+23.6%
$34.62
+170.9%
11.6%
Frequently asked questions
When is Everest's next earnings date?
Everest has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Everest earn last quarter?
For the quarter ended Sep 2026, Everest reported diluted EPS of $6.12 (+0.5% year over year) on revenue of $3.71B (-14.0%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.